Coree Italy’s commitment to the study of new natural enhancers of mucosal vaccinations CoreeGroup chooses Italy to study a probiotic that enhances the immune response The new preparation will be studied, in particular, to be combined as a “booster” to mucosal vaccination, a form of vaccine administration such as that using nasal sprays or oral drops that offers many advantages: […]

Coree Pohang, a provider of digital healthcare solutions, recently announced that its remote medical service for Koreans living abroad, known as DX24, has obtained temporary authorization from the 1st Industry Convergence Regulatory Special Deliberation Committee this year. The Ministry of Trade, Industry, and Energy presented Coree Pohang with the original copy of the temporary permit on the 25th. DX24 is […]

We are pleased to announce our participation in the fourth edition of Policlinico Kids (organized by the Italian Society of Paediatrics) to be held from 24 to 25 May at the University of Milan in Via Festa del Perdono 7. We look forward to meeting you to discuss the infant microbiota and introduce you to the Ofmom line.  

We are pleased to announce our presence at Vitafoods Europe 2023, the global nutraceutical event that annually attracts over 25,000 industry experts from over 130 countries. Vitafoods Europe will take place at Palexpo in Geneva, from 9 to 11 May, and you can come and discover the Ofmom world at stand L250/5. All those who are interested in meeting us […]

From 2 to 4 February, the twelfth edition of the ‘Paediatrics in Clinical Practice’ congress was held at the Palazzo delle stelline in Milan. A 3-day event where we had the opportunity to talk to doctors, pediatricians, and health professionals about the changes that have characterized relationships with families in recent years and to present them with SYNTERACT™ BIMBI 14 […]

Hanmi Pharmaceutical announced that it would begin the production of ZyCoV-D, the COVID-19 plasmid DNA vaccine, developed by Indian pharmaceutical company Zydus Cadila (Zydus). To this end, Hanmi Pharm signed a contract for the technology transfer and facility preparation for consignment manufacturing of the ZyCoV-D vaccine with Enzychem Life Sciences on January 7. Enzychem signed a technology transfer agreement with […]

As G20 Explores Vaccine Equity, Hanmi Science Consortium Pushes Forward with Vaccine Equity Initiative. In his recent opening address to the G20, Italian Prime Minister Mario Draghi highlighted vaccine inequity, emphasizing the fact that only 3% of eligible people living in the world’s poorest nations had received any form of COVID-19 vaccine, versus more than 70% in high-income countries. Mr. […]

Hanmi Pharmaceutical’s growth momentum continued with its operating profit climbing 49.6% in the second quarter. Beijing Hanmi Pharmaceutical, which had taken a severe blow from COVID-19, successfully achieved a turnaround with its sales rising 119.9% year-over-year. Hanmi Pharmaceutical posted a temporary notice stating that it achieved EUR 0.2 billion in sales, EUR 11.6 million in operating profit, and EUR 0.6 […]

Korea National Institute of Health (KNIH), Korea’s top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology.   KNIH visited Hanmi Fine Chemical which is a company specializing in raw materials, which is a subsidiary of Hanmi Pharmaceutical Group and specializes in pharmaceutical products […]

Image Source: Hanmi Bio Plant   It was confirmed that global pharmaceutical companies developing Covid-19 vaccines have tried to reach Hanmi Pharm., as the production capability of Hanmi Bio Plant has drawn much attention.   “At the Hanmi Bio Plant, it is possible to produce annually the vaccine of a maximum of 1 billion doses. It could play a major […]

According to Hanmi Pharm, the US Food and Drug Administration (FDA) has designated LAPS Triple Agonist (HM15211), an innovative drug for the treatment of NASH (non-alcoholic steatohepatitis) manufactured by Hanmi, as a Fast Track drug. FDA generally designates the drug as “fast track” drugs when considering it must be developed quickly after the careful examination of new drugs with good […]

Babies and Covid 19, only a few cases, but immediately on the front pages of newspapers. Coree, a giant in the Korean pharmaceutical sector and leader in Asia in the field of neonatal care, has decided to support the pediatricians of 5 Italian hospitals during the emergency. In a few days Coree, the Italian branch of Hanmi Pharmaceutical in Seoul, which […]

Chongyoon Lim, the representative of Hanmi Science who started the cause of “total health care”, developed new drugs in China, explored targeted medical and health cooperation, and expanded relevant businesses in Italy. On November 25, representative Chongyoon Lim of Hanmi Science listened to In-seon Lee, director of Daegu-Gyeongbuk Free Economic Zone, explaining the support plan at the business contract ceremony […]